POC

1 stories · following the connections

Business

AXIM Biotech Enters Services Agreement With Israel-Based CRO to Begin Clinical POC Study on CBD and Gabapentin Chewing Gum for Treatment of Restless Leg Syndrome

By Nasdaq OMXJul 20, 2017, 1:00 PM UTC